This study records a threefold higher level of ZnT-4 gene expression levels in normal prostate compared to other normal tissue, and a fivefold higher level in prostate cancer compared to other types of male tissue analyzed [86]. The gene discussed is SLC30A4; the disease is prostate carcinoma.